Skip to main content

Ambulatory Blood Pressure Monitoring in Special Populations: Masked Hypertension

  • Chapter
Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 1335 Accesses

Abstract

The term “masked hypertension” refers to elevated out-of-clinic average blood pressure (BP) in the context of a recently measured non-elevated clinic BP. The gold standard for out-of-office BP determination is ambulatory BP monitoring. In general population studies, approximately 10 % of adults have masked hypertension. Among adult patients seen in clinical settings, 15–30 % with non-elevated clinic BP have masked hypertension. Masked hypertension is associated with increased risk of cardiovascular morbidity and mortality that approaches that of sustained hypertension (elevated office and elevated ambulatory BP). The increased cardiovascular risk coupled with a failure to be diagnosed by the conventional approach of clinic BP measurement makes masked hypertension a significant health problem. The best approach to use in the clinical setting to detect masked hypertension remains unknown. Home BP monitoring is an alternative to ambulatory BP monitoring, but it is not clear that home BP monitoring is an adequate substitute.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40(6):795–6.

    Article  PubMed  CAS  Google Scholar 

  2. O’Brien E, Parati G, Stergiou G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68.

    PubMed  Google Scholar 

  3. O’Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23(4):697.

    Article  PubMed  Google Scholar 

  4. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–53.

    Article  PubMed  CAS  Google Scholar 

  5. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19(3):243–50.

    Article  PubMed  Google Scholar 

  6. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508–15.

    Article  PubMed  Google Scholar 

  7. Shimbo D, Newman JD, Schwartz JE. Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens. 2012;25(6):664–71.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107(9):1297–302.

    Article  PubMed  Google Scholar 

  9. Hanninen M-RA, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. J Hypertens. 2012;30:705–12.

    Article  PubMed  Google Scholar 

  10. Peacock J, Diaz KM, Viera AJ, Schwartz JE, Shimbo D. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28(9):521–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. Imai Y, Tsuji I, Nagai K, et al. Ambulatory blood pressure monitoring in evaluating the prevalence of hypertension in adults in Ohasama, a rural Japanese community. Hypertens Res. 1996;19(3):207–12.

    Article  PubMed  CAS  Google Scholar 

  12. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104(12):1385–92.

    Article  PubMed  CAS  Google Scholar 

  13. Márquez Contreras E, Casado Martínez JJ, Pardo Alvarez J, Vázquez I, Guevara B, Rodríguez J. Prevalence of white-coat hypertension and masked hypertension in the general population, through home blood pressure measurement. Aten Primaria. 2006;38(7):392–8.

    Article  PubMed  Google Scholar 

  14. Belkić KL, Schnall PL, Landsbergis PA, et al. Hypertension at the workplace—an occult disease? The need for work site surveillance. Adv Psychosom Med. 2001;22:116–38.

    Article  PubMed  Google Scholar 

  15. Selenta C, Hogan BE, Linden W. How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med. 2000;9:533–40.

    Article  PubMed  CAS  Google Scholar 

  16. Gorostidi M, Vinyoles E, Banegas JR, de la Sierra A. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res. 2015;38(1):1–7.

    Article  PubMed  Google Scholar 

  17. Franklin SS, Thijs L, Li Y, et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension. 2013;61(5):964–71.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  18. Leitao CB, Canani LH, Silveiro SP, Gross JL. Ambulatory blood pressure monitoring and type 2 diabetes mellitus. Arq Bras Cardiol. 2007;89:315–21; 347–54.

    Article  PubMed  Google Scholar 

  19. Ben-Dov IZ, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med. 2007;167:2139–42.

    Article  PubMed  Google Scholar 

  20. Gorostidi M, Sarafidis PA, de la Sierra A. et al; Spanish ABPM Registry Investigators. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. Am J Kidney Dis. 2013;62(2):285–94.

    Article  PubMed  Google Scholar 

  21. Pogue V, Rahman M, Lipkowitz M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53:20–7.

    Article  PubMed  CAS  Google Scholar 

  22. Baguet JP, Levy P, Barone-Rochette G, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens. 2008;26(5):885–92.

    Article  PubMed  CAS  Google Scholar 

  23. Drager LF, Diegues-Silva L, Diniz PM, et al. Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens. 2010;23(3):249–54.

    Article  PubMed  Google Scholar 

  24. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131(8):564–72.

    Article  PubMed  CAS  Google Scholar 

  25. Matsui Y, Eguchi K, Ishikawa J, Hoshide S, Shimada K, Kario K. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement. Am J Hypertens. 2007;20:385–91.

    Article  PubMed  Google Scholar 

  26. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193–8.

    Article  PubMed  CAS  Google Scholar 

  27. Hansen TW, Kikuya M, Thijs L, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25(8):1554–64.

    Article  PubMed  CAS  Google Scholar 

  28. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: Royal College of Physicians; 2011.

    Google Scholar 

  29. Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive services task force. Ann Intern Med. 2015;162(3):192–204.

    Article  PubMed  Google Scholar 

  30. Viera AJ, Lin FC, Tuttle LA, et al. Levels of office blood pressure and their operating characteristics for detecting masked hypertension based on ambulatory blood pressure monitoring. Am J Hypertens. 2015;28(1):42–9.

    Article  PubMed  Google Scholar 

  31. Hanninen M-RA, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens. 2011;29:1880–8.

    Article  PubMed  Google Scholar 

  32. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R. Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens. 2010;23(11):1190–7.

    Article  PubMed  Google Scholar 

  33. Viera AJ, Lin FC, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, Klein JL, Hinderliter AL. Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014;19(4):208–15.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.

    Article  PubMed  CAS  Google Scholar 

  35. Zhuo S, Wen W, Li-Yuan M, Shu-Yu W, Yi-Xin W. Home blood pressure measurement in prehypertension and untreated hypertension: comparison with ambulatory blood pressure monitoring and office blood pressure. Blood Press Monit. 2009;14:245–50.

    Article  PubMed  Google Scholar 

  36. Stergiou GS, Argyraki KK, Moyssakis I, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20:616–21.

    Article  PubMed  Google Scholar 

  37. Matsui Y, Eguchi K, Ishikawa J, Hoshide S, Shimada K, Kario K. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement. Am J Hypertens. 2007;20(4):385–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony J. Viera M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Viera, A.J. (2016). Ambulatory Blood Pressure Monitoring in Special Populations: Masked Hypertension. In: White, W. (eds) Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Clinical Hypertension and Vascular Diseases. Humana Press, Cham. https://doi.org/10.1007/978-3-319-22771-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22771-9_16

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-22770-2

  • Online ISBN: 978-3-319-22771-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics